Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Menlo Park, California 94025


Purpose:

To provide Stealth liposomal doxorubicin hydrochloride ( DOX-SL ) as a therapy for Kaposi's sarcoma patients who have no remaining treatment options other than DOX-SL or patients who have been participating in another DOX-SL protocol and for whom continuation in DOX-SL is medically indicated. Also, to evaluate the safety and efficacy of DOX-SL in patients with Kaposi's sarcoma who have previously received systemic chemotherapy with or without an anthracycline.


Study summary:

Patients receive DOX-SL every 3 weeks for up to 20 cycles.


Criteria:

Inclusion Criteria Patients must have: - AIDS-related Kaposi's sarcoma that requires systemic chemotherapy. - EITHER a medical indication for continuation of DOX-SL following treatment on another DOX-SL protocol, OR no remaining treatment options other than DOX-SL. Prior Medication: Allowed: - Prior anthracyclines. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Cardiac ejection fraction < 50 percent or clinically significant cardiac disease. - Eligibility for a Liposomal Technology comparative protocol. Concurrent Medication: Excluded: - Other cytotoxic chemotherapy. Patients with the following prior condition are excluded: History of idiosyncratic or allergic reaction to anthracyclines. Prior Medication: Excluded: - Chemotherapy within the past 3 weeks.


NCT ID:

NCT00002147


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Menlo Park, California 94025
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.